Cure Parkinson’s
16 results.
In less than a month, scientists, physicians and people with Parkinson’s will gather at Van Andel Research Institute with one goal in mind—finding a cure…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
New data published today shows drug preserves critical brain function in laboratory models of Parkinson’s GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally…
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…
Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on an initiative to…
Meeting held in Grand Rapids, Mich., aims to increase the effectiveness and efficiency of the Parkinson’s disease clinical trial system
Grand…